Cargando…

Effects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancer

The present study aimed to investigate the effect of the negative costimulatory molecule programmed death-ligand 1 (PD-L1) on immunotherapy with OK-432, following transurethral resection of bladder tumors in non-muscle invasive bladder cancer (NMIBC), and to elucidate the underlying mechanism. PD-L1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhi-Hua, Zheng, Fu-Fu, Mao, Yu-Ling, Ye, Lie-Fu, Bian, Jun, Lai, De-Hui, Ye, Yun-Lin, Dai, Yu-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453062/ https://www.ncbi.nlm.nih.gov/pubmed/28599483 http://dx.doi.org/10.3892/ol.2017.6080

Ejemplares similares

Percutaneous Treatment of Renal Cysts with OK-432 Sclerosis
por: Choi, Young Deuk, et al.
Publicado: (2007)

OK-432 Treatment of Ranula Intruding into the Cervical Region
por: Ohta, Nobuo, et al.
Publicado: (2022)

CD40 monoclonal antibody and OK432 synergistically promote the activation of dendritic cells in immunotherapy
por: Zhang, Juan, et al.
Publicado: (2022)

Picibanil (OK-432) in the treatment of head and neck lymphangiomas in children
por: Rebuffini, Elena, et al.
Publicado: (2012)

Successful pleurodesis with OK-432 in preterm infants with persistent pleural effusion
por: Kim, Jeong Eun, et al.
Publicado: (2012)

OK432 sclerotherapy for refractory chylous leakage after neck dissection
por: Hashimoto, Yuiko, et al.
Publicado: (2023)

Transurethral needle electrode resection and transurethral holmium laser resection of bladder cancer
por: Zhou, Yu, et al.
Publicado: (2020)

The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients
por: Gochi, A, et al.
Publicado: (2001)

Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation
por: Olsnes, Carla, et al.
Publicado: (2009)

Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432
por: Morimoto, Yoshihito, et al.
Publicado: (2018)

Response to OK-432 sclerotherapy in the treatment of cervical lymphangioma with submucosal extension to the airway()
por: Manzini, Michelle, et al.
Publicado: (2016)

Immunotherapy with Subcutaneous Injection of Immunomodulatory Agent (OK-432) Elicits Durable Response in Locally Advanced or Relapsed Cervical Cancer
por: Alas, Quenny Michelle Dyan A., et al.
Publicado: (2019)

Efficacy of OK-432 sclerotherapy for different types of lymphangiomas: a review and meta-analysis
por: Sun, Jiali, et al.
Publicado: (2023)

Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity
por: Koya, Terutsugu, et al.
Publicado: (2017)

The usefulness of OK‐432 for the treatment of postoperative chylothorax in a low‐birth‐weight infant with trisomy 18
por: Takahashi, Yoshiaki, et al.
Publicado: (2022)

Successful treatment of hepatic lymphorrhea by percutaneous transhepatic lymphangiography followed by sclerotherapy using OK-432
por: Kojima, Masayuki, et al.
Publicado: (2019)

Percutaneous sclerotherapy with OK-432 for lymphocele after pelvic or para-aortic lymphadenectomy: preliminary results
por: Kashiwagi, Eiji, et al.
Publicado: (2022)

Non-functional paraganglioma of urinary bladder managed by transurethral resection
por: Qiao, Baomin, et al.
Publicado: (2019)

The Cytocidal Activity of OK‐432‐activated Mononuclear Cells against Human Glioma Cells is Partly Mediated through the Fas Ligand/Fas System
por: Toda, Keisuke, et al.
Publicado: (1996)

The Changing Pattern of the Splenic Lymphocyte Subsets in Tumor‐bearing Mice after Oral Treatment with OK‐432
por: Akamatsu, Yoshihiko, et al.
Publicado: (1992)

OK-432 Acts as Adjuvant to Modulate T Helper 2 Inflammatory Responses in a Murine Model of Asthma
por: Wu, Cheng-Jang, et al.
Publicado: (2018)

Treatment of lymphangiomas by means of sclerotherapy with OK-432 (Picibanil®) is safe and effective – A retrospective case series
por: Fasching, G., et al.
Publicado: (2022)

Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation
por: Cao, Yanyan, et al.
Publicado: (2023)

Management of bladder pheochromocytoma by transurethral resection
por: Sharma, Aditya P., et al.
Publicado: (2019)

Transurethral resection of bladder tumour (TURBT)
por: Kim, Lawrence H. C., et al.
Publicado: (2020)

The Soluble Factor from Oral Cancer Cell Lines Inhibits Interferon-γ Production by OK-432 via the CD40/CD40 Ligand Pathway
por: Ohe, Go, et al.
Publicado: (2021)

Transurethral resection syndrome: A rare complication of intraperitoneal bladder perforation during transurethral resection of bladder tumor
por: Ibrahimi, Ahmed, et al.
Publicado: (2020)

Promising abscopal effect of combination therapy with thermal tumour ablation and intratumoural OK-432 injection in the rat osteosarcoma model
por: Iwai, Tadashi, et al.
Publicado: (2020)

Correction: Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation
por: Cao, Yanyan, et al.
Publicado: (2023)

Utility of restage transurethral resection of bladder tumor
por: Manoharan, Vignesh, et al.
Publicado: (2018)

Technical developments in transurethral resection of bladder tumours
por: Pastuszak, Agata, et al.
Publicado: (2019)

Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis
por: Wu, Yu-Peng, et al.
Publicado: (2016)

Bladder injury secondary to obturator reflex is more common with plasmakinetic transurethral resection than monopolar transurethral resection of bladder cancer
por: Ozer, Kutan, et al.
Publicado: (2015)

OK-432 Administration Inhibits Murine Allergic Rhinitis at the Induction Phase, through the Macrophage Activation with TLR2 Signaling Pathway
por: Aoi, Noriaki, et al.
Publicado: (2018)

Safety and Long-Term Outcome of Intratumoral Injection of OK432-Stimulated Dendritic Cells for Hepatocellular Carcinomas After Radiofrequency Ablation
por: Kitahara, Masaaki, et al.
Publicado: (2020)

Comparison of the Efficacy and Safety of Single-Session OK-432 and Multiple-Session 99% Ethanol Sclerotherapy for Symptomatic Simple Hepatic Cysts
por: Mo, Zhiqiang, et al.
Publicado: (2022)

Extraperitoneal bladder perforation secondary to transurethral resection of bladder tumor
por: Luu, Doan Tien, et al.
Publicado: (2021)

Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors
por: Sun, Kai, et al.
Publicado: (2021)

Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses
por: Hovden, Arnt-Ove, et al.
Publicado: (2011)

Obturator Nerve Block for Transurethral Resection of Bladder Tumors
por: Gavrilovska-Brzanov, Aleksandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1vvvfnedfjjopqjae14h4en25d